Formulation, development, and evaluation of floating pulsatile drug delivery system of atenolol

PDA Journal of Pharmaceutical Science and Technology

Volumn 67, Issue 3, 2013, Pages 214-228

  Jagdale, Swati C ^a   Sali, Monali S ^a   Barhate, Ajay L ^a   Kuchekar, Bhanudas S ^a   Chabukswar, Aniruddha R ^a  

^a MAEER S MAHARASHTRA INSTITUTE OF PHARMACY   (India)

Author keywords

Atenolol; Chronotherapy; Floating drug delivery; Pulsatile; Tablet

Indexed keywords

ATENOLOL; BICARBONATE; CITRIC ACID; HYDROXYPROPYLMETHYLCELLULOSE; POLYMER; DELAYED RELEASE FORMULATION; TABLET;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; FLOATING PULSATILE DRUG DELIVERY SYSTEM; HYDROPHILICITY; IN VITRO STUDY; IN VIVO STUDY; PROCESS DEVELOPMENT; TABLET; TABLET FRIABILITY; X RAY; ADMINISTRATION AND DOSAGE; DELAYED RELEASE FORMULATION; MEDICINAL CHEMISTRY;

ATENOLOL; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; TABLETS;

EID: 84879391189     PISSN: 10797440     EISSN: 19482124     Source Type: Journal    
DOI: 10.5731/pdajpst.2013.00916     Document Type: Article

References (30)

1. Lemmer, B. Chronopharmacokinetics: implications for drug treatment. J. Pharm. Pharmacol. 1999, 51 (8), 887.
2. Kalantzi, L. E; Karavas, E.; Koutris, E. X.; Bikiaris, D. N. Recent advances in oral pulsatile drug delivery. Recent Pat. Drug Deliv. Formul. 2009, 3 (1), 49-63.
3. Singh, B. N. Modified-release solid formulations for colonic delivery. Recent Pat. Drug Deliv. Formul. 2007, 1 (1), 53-63.
4. Ueda, S.; Hata, T.; Asakura, S.; Yamaguchi, H.; Ueda Y. Development of a novel drug release system, time controlled explosion system (TES). Part Concept and design. J. Drug Target. 1994, 2 (1), 35-44.
5. Arvidson, N. G.; Gudbjörnsson, B.; Elfman, L.; Rydén, A. C.; Tötterman, T. H.; Hällgren, R. Circadian rhythm of secum interleucin-6 in rhematiod arthritis. Ann. Rheum. Dis. 1994, 53 (8), 521-524.
6. Barnes, J. P. Circadian variation in airway function. Am. J. Med. 1985, 79 (6A), 5-9.
7. Fox, K. M.; Mulcahy, D. A. Circadian rhythms in cardiovascular diseases. Postgrad. Med. J. 1991, 67, S33-S36.
8. Millar-Craig, M. W.; Bishop, C. N.; Raftery, E. B. Circadian variation of blood pressure. Lancet 1978, 1 (8068), 795-797.
9. McTavish, D.; Sorkin, E. M. Verapamil: an updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in hypertension. Drugs 1989, 38, 19-76.
10. Bussemer, T.; Dashevsky, A.; Bodmeier, R. A pulsatile drug delivery system based on rupturable coated hard gelatin capsules. J. Controlled Release 2003, 93 (3), 331-339.
11. Bussemer, T.; Peppas, N. A.; Bodmeier, R. Evaluation of the swelling, hydration and rupturing properties of the swelling layer of a rupturable pulsatile drug delivery system. Eur. J. Pharm. Biopharm. 2003, 56 (2), 261-270.
12. Dashevsky, A.; Mohamad, A. Development of pulsatile multiparticulate drug delivery system coated with aqueous dispersion Aquacoat ECD. Eur. J. Pharm. Biopharm. 2006, 318 (1-2), 124-131.
13. Karavas, E.; Georgarakis, E.; Bikiaris, D. Application of PVP/HPMC miscible blends with enhanced mucoadhesive properties for adjusting drug release in predictable pulsatile chronotherapeutics. Eur. J. Pharm. Biopharm. 2006, 64 (1), 115-126.
14. Magruder, P. R.; Barclay, B.; Wong, P. S. L.; Theeuwes, F. Composition Comprising Salbutamol, U.S. Patent 4,751,071, 1988.
15. Cutler, N.; Anders, R.; Stanford, S.; Stramed, J.; Awan, N.; Bultas, J.; Lahari, A.; Woroszylska, M. Placebo-controlled evaluation of three doses of a controlled-onset, extended-release formulation of verapamil in the treatment of stable angina pectoris. Am. J. Cardiol. 1995, 75 (16), 1102-1106.
16. Conte, U.; Colombo, P.; La Manna, A.; Gazzaniga, A.; Sangalli, M. E.; Giuchedi, P. A new ibuprofen pulsed release oral dosage form. Drug Dev. Ind. Pharm. 1989, 15 (14-16), 2583-2596.
17. Conte, U.; Maggi, L.; Torre, M. L.; Giunchedi, P.; La Manna, A. Press-coated tablets for time-programmed release of drugs. Biomaterials 1993, 14 (13), 1017-1023.
18. Conte, U.; Maggi, L. Modulation of the dissolution profiles from Geomatrix multi-layer matrix tablets containing drug of different solubility. Biomaterials 1996, 17 (9), 889-896.
19. Hedben, J.; Wilson, C.; Spiller, R.; Gilchrist, P.; Blackshaw, E.; Frier, M.; Perkins, A. Regional differences in quinine absorption from the undisturbed human colon assessed using a timed release delivery system. Pharm. Res. 1999, 16 (7), 1087-1092.
20. Ghika, J.; Gashoud, J. P.; Gasser, U. Clinical efficacy and tolerability of a new levodopa/ benserazide dual-release formulation in parkinsonian patients. Clin. Neuropharmacol. 1997, 20 (2), 130-139.
21. Sharma, S.; Pawar, A. Low density multiparticulate system for pulsatile release of meloxicam. Int. J. Pharm. 2006, 313 (1-2), 189-197.
22. Li, S.; Daggy, B. P.; Mirchandani, H. L.; Chien, Y. W. Effect of HPMC and carbopol on the release and floating properties of gastric floating drug delivery system using factorial design. Int. J. Pharm. 2003, 253 (1-2), 13-22.
23. Khanna, R.; Agarwal, S. P.; Ahuja, A. Mucoadhesive buccal tablets of clotrimazole for oral candidiasis. Drug Dev. Ind. Pharm. 1997, 23 (8), 831-837.
24. Singh, B. N.; Kim, K. H. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J. Controlled Release 2000, 63 (3), 235-259.
25. Arora, S.; Ali, J.; Ahuja, A.; Khar, R. K.; Baboota, S. Floating drug delivery systems: a review. AAPS PharmSciTech 2005, 6 (3), E372-E390.
26. Baumgartner, S.; Kristl, J.; Vrecer, F.; Vodopivec, P.; Zorko, B. Optimisation of floating matrix tablets and evaluation of their gastric residence time. Int. J. Pharm. 2000, 195 (1-2), 125-135.
27. Satwara, R. S.; Patel, P. K. Formulation and optimization of chronomodulated press-coated tablet of carvedilol by Box-Behnken statistical design. ChronoPhysiology and Therapy 2012, 2 (1), 35-50.
28. Zilpe, C. R.; Dhumale, A. J.; Gudalwar, B. R.; Kawtikwar, P. S.; Sakarkar, D. M. Development and evaluation of pulsatile press coated tablet to control early morning BP surge. Int. J. Pharm. World Res. 2012, 3 (2), 1-19.
29. Sibel, B. P.; Suba, B. R.; Vural, I.; Unlu, N.; Capan, Y. Evaluation of drug-excipient interaction in the formulation of celecoxib tablets. Acta Poloniae Pharmaceutica Drug Res. 2011, 68 (3), 423-433.
30. Moon, A.; Kondawar, M.; Shah, R. Formulation and evaluation of press-coated indomethacin tablets for pulsatile drug delivery system. J. Pharm. Res. 2011, 4 (3), 564-566.